☆ 3.8 Review

The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs

Elisa Russo et al.

Summary: This study demonstrates that uric acid (UA) can induce changes in VSMC cytoskeleton, leading to increased cell migration and activation of specific signaling pathways. These findings suggest that UA may play a critical role in vascular remodeling, emphasizing the importance of interventions to prevent the development of cardiovascular diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Peripheral Vascular Disease

Serum uric acid/serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values

Edoardo Casiglia et al.

Summary: In the URRAH study, we identified the cut-off value for the ratio of serum uric acid (SUA) to serum creatinine (sCr) that can predict cardiovascular events. We found that having SUA/sCr > 5.35 is an independent cardiovascular risk indicator for both men and women.

JOURNAL OF HYPERTENSION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level

Paolo Palatini et al.

Summary: This study investigates the association between very high HDL-cholesterol levels and cardiovascular mortality (CVM), and whether this association is influenced by hyperuricemia. The results show a J-shaped association between high HDL-cholesterol levels and CVM in women, but not in men. Additionally, the risk of CVM related to high HDL-cholesterol is increased in women with hyperuricemia.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Serum uric acid significantly improves the accuracy of cardiovascular risk score models

Yonatan Moshkovits et al.

Summary: This study evaluated the impact of serum uric acid (sUA) on the accuracy of pooled cohort equations (PCE) model, Systematic COronary Risk Evaluation 2 (SCORE2), and SCORE2-older persons. The results showed that sUA significantly improved the classification accuracy of these models, especially among normal-weight and low-risk subjects.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Add to Collection

Article Cell Biology

The global burden of metabolic disease: Data from 2000 to 2019

Nicholas W. S. Chew et al.

Summary: Global estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 reveal increasing prevalence rates for metabolic diseases, particularly in high socio-demographic index countries. While mortality rates have decreased for some metabolic diseases, such as hyperlipidemia, hypertension, and non-alcoholic fatty liver disease, rates remain unchanged for type 2 diabetes mel-litus and obesity. The highest mortality rates are observed in the World Health Organization Eastern Mediterranean region and low to low-middle socio-demographic index countries.

CELL METABOLISM (2023)

Add to Collection

Article Medicine, General & Internal

Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project

Maria Lorenza Muiesan et al.

Summary: The study found a significant association between serum uric acid (SUA) and left ventricular mass index (LVMI), and the combination of hyperuricemia with left ventricular hypertrophy (LVH) can predict the risk of cardiovascular (CV) death.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Review Peripheral Vascular Disease

Update in uric acid, hypertension, and cardiovascular diseases

Masanari Kuwabara et al.

Summary: Many studies have reported a direct relationship between serum uric acid levels and hypertension, cardiovascular, renal, and metabolic diseases. While there is a clinical association between uric acid and high blood pressure, it is still unclear whether lowering uric acid is beneficial for preventing cardiovascular and renal metabolic diseases.

HYPERTENSION RESEARCH (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential

Arrigo F. G. Cicero et al.

Summary: Purines, such as adenine and guanine, have various important roles in cells, including being found in nucleic acids, serving as structural components of coenzymes, and playing crucial roles in energy metabolism and signal transduction. They also contribute significantly to the physiology of platelets, muscles, and neurotransmission. Maintaining a balanced purine ratio is essential for cell growth, proliferation, and survival. Dysfunctions in purine metabolism, such as hyperuricemia, have been associated with certain human diseases, particularly cardiovascular ones. Investigating purine metabolism dysfunctions, the functionality of xanthine oxidoreductase, and the formation of catabolites in urine and saliva can provide insights and potential markers for oxidative stress.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study

Alessandro Mengozzi et al.

Summary: High serum uric acid (SUA) levels have been found to predict all-cause mortality (ACM) and cardiovascular mortality (CVM) in cardiometabolic patients without established cardiovascular disease, regardless of triglyceride (TG) levels. The study included 8124 patients from the URic acid Right for heArt Health (URRAH) study cohort, and the findings were confirmed by exploratory and sensitivity analyses. This suggests that SUA plays a substantial role in predicting cardiovascular risk in both normotriglyceridemia and hypertriglyceridemia.

METABOLITES (2023)

Add to Collection

Article Endocrinology & Metabolism

Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes

Benchao Li et al.

Summary: This study found that serum uric acid (SUA) level is associated with all-cause and cardiovascular disease (CVD) mortality in individuals with diabetes. Higher SUA levels are associated with increased risks of all-cause and CVD mortality. Interventional studies are needed to evaluate the health effect of treatments to lower SUA levels in clinical practice.

DIABETES CARE (2023)

Add to Collection

Article Peripheral Vascular Disease

Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study

Valerie Tikhonoff et al.

Summary: The study aimed to identify prognostic cut-off values of serum uric acid for cardiovascular risk, demonstrating that SUA is an independent risk marker for cerebrovascular events and identifying >4.79 mg/dL as a valid prognostic cut-off value.

JOURNAL OF HUMAN HYPERTENSION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study

Fangkun Yang et al.

Summary: Using Mendelian randomization method, this study found a causal effect of genetically predicted elevated serum urate levels on coronary heart disease (CHD) and myocardial infarction (MI), while the reverse effect of CHD or MI on serum urate levels was not evident. These findings suggest that urate-lowering therapy may be beneficial in the prevention of CHD and MI.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project

Maria Masulli et al.

Summary: The SUA thresholds proposed by the URRAH study are also predictive of total and CV mortality in people with diabetes, with a threshold of 5.6 mg/dl being a candidate clinical cut-off for defining hyperuricemia in diabetic patients.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid

Paolo Palatini et al.

Summary: The association between high uric acid and cardiovascular mortality risk was found to be influenced by the level of resting heart rate, with participants with median HR having lower cardiovascular mortality risk.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Urology & Nephrology

Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project

Elisa Russo et al.

Summary: The study analyzed clinical data of 26,971 individuals and found that serum uric acid levels were positively correlated with kidney disease measures (eGFR and albuminuria), especially in cases of renal function decline.

JOURNAL OF NEPHROLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

New Way to SCORE Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines

Ian M. Graham et al.

Summary: Published in 2021, the updated risk scores allow for estimation of 10-year total risks of a first atherosclerotic cardiovascular event in adults (SCORE2) and older persons (SCORE2-OP), calibrated for use in four European risk regions. These models account for competing risk of non-CVD death and have been extensively validated with excellent calibration and C-statistics ranging from 0.67 to 0.81. SCORE2 and SCORE2-OP have informed the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

CURRENT CARDIOLOGY REPORTS (2022)

Add to Collection

Review Urology & Nephrology

Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials

Tunlanut Sapankaew et al.

Summary: The results of the study suggest that allopurinol and febuxostat are the preferred ULTs for reducing composite renal events and improving renal function.

BMC NEPHROLOGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials

Alicia Swee Yan Yip et al.

Summary: This study conducted a systematic review and meta-analysis to evaluate the effect of SGLT2 inhibitors on serum urate levels in patients with and without diabetes. The results showed that SGLT2 inhibitors significantly reduced urate levels in both patient groups, contributing to the treatment of hyperuricaemia.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2022)

Add to Collection

Article Peripheral Vascular Disease

Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study

Maria L. Muiesan et al.

Summary: The study confirms that SUA is an independent risk factor for all heart failure and fatal heart failure, and shows that prognostic cut-off values can be identified for all heart failure (>5.34 mg/dL) and fatal heart failure (>4.89 mg/dL).

JOURNAL OF HYPERTENSION (2021)

Add to Collection

Review Rheumatology

The role of diet in hyperuricemia and gout

Chio Yokose et al.

Summary: Gout is closely associated with insulin resistance and is considered a manifestation of the metabolic syndrome. Recent research suggests that healthy diets like the Mediterranean or DASH diets, along with weight loss for overweight or obese individuals, can significantly improve cardiometabolic risk factors and outcomes. By treating gout as part of the metabolic syndrome and shifting dietary recommendations to healthy patterns, the beneficial effects on gout endpoints can be naturally achieved.

CURRENT OPINION IN RHEUMATOLOGY (2021)

Add to Collection

Article Peripheral Vascular Disease

Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study

Alessandro Maloberti et al.

Summary: This study aimed to investigate the relationship between diuretic-related hyperuricemia and cardiovascular events, showing that individuals with diuretic-related hyperuricemia have a similar risk of cardiovascular events compared to those with hyperuricemia without diuretic therapy.

JOURNAL OF HYPERTENSION (2021)

Add to Collection

Review Medicine, General & Internal

Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update

Arrigo F. G. Cicero et al.

Summary: Xanthine oxidase inhibitors are found to be the safest and most effective uric acid lowering drugs for chronic hyperuricemia, while the efficacy of uricosuric agents is strongly modulated by pharmacogenetics. Emerging drugs show promise for the acute management of refractory hyperuricemia, but further well-designed clinical research is needed to deepen their efficacy and safety profile.

MEDICINA-LITHUANIA (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk

Nicola Riccardo Pugliese et al.

Summary: The study found that elevated serum uric acid levels were associated with a higher risk of cardiovascular mortality regardless of the presence of metabolic syndrome. A cardiovascular uric acid threshold may improve risk stratification.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Add to Collection

Article Peripheral Vascular Disease

Urate, Blood Pressure, and Cardiovascular Disease Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials

Dipender Gill et al.

Summary: Mendelian randomization analysis suggests that genetically predicted serum urate levels are associated with increased risk of coronary heart disease, peripheral artery disease, and stroke. Elevated blood pressure may mediate a significant portion of the effect of urate on cardiovascular disease risk. High-quality trials are needed to determine the specific clinical contexts where lowering urate levels may benefit cardiovascular health.

HYPERTENSION (2021)

Add to Collection

Article Medicine, General & Internal

The URRAH study

Rita Del Pinto et al.

Summary: Studying serum uric acid levels has revealed associations with various diseases and risks, including cardiovascular deaths. The identified cut-off values within normal ranges can predict total and cardiovascular mortality.

PANMINERVA MEDICA (2021)

Add to Collection

Review Medicine, General & Internal

Treating Hyperuricemia: The Last Word Hasn't Been Said Yet

Elisa Russo et al.

Summary: Gout and asymptomatic hyperuricemia are associated with traditional cardiovascular risk factors and chronic kidney disease. Recent trials have failed to show the benefits of allopurinol treatment on kidney outcomes, raising doubts on renal protection expectations from urate lowering treatment. The study aims to provide possible explanations for the lack of effect of urate lowering treatment on chronic kidney disease progression.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Nutrition & Dietetics

Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood

Dorota Drozdz et al.

Summary: Obesity is a major epidemic in the 21st century that increases the risk of various cardiometabolic factors. Early recognition of CV damage and prevention strategies are crucial in reducing CV morbidity and mortality. Recognizing and tracking risk factors from prenatal age to adulthood is essential in addressing the impact of obesity on cardiovascular health.

NUTRIENTS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Stefan J. Schunk et al.

Summary: The NLRP3 intronic variant rs10754555 is associated with increased systemic inflammation, inflammasome activation, prevalent coronary artery disease, and mortality. This study provides evidence for a substantial role of genetically driven systemic inflammation in CVD and highlights the NLRP3 inflammasome as a therapeutic target.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project

Elisa Russo et al.

Summary: The study demonstrates that hyperuricemia is a risk factor for cardiovascular and all-cause mortality, with an additive effect in patients at cardiovascular risk when combined with eGFR strata and albuminuria. Serum uric acid and eGFR significantly interact in determining mortality risk.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Hangying Ying et al.

Summary: XOI-induced reduction in UA levels is associated with decreased incidence of MACEs. However, the effect of febuxostat and allopurinol treatments on cardiovascular events is not significant. Overall, UA-lowering medications do not have a significant impact on cardiovascular outcomes.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs

Federica Fogacci et al.

Summary: The study reveals that women and racial and ethnic minorities are underrepresented in controlled clinical trials testing SUA-lowering drugs, with a similar pattern across different drug classes.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Stefan J. Schunk et al.

Summary: The NLRP3 intronic variant rs10754555 is associated with increased systemic inflammation, inflammasome activation, prevalent coronary artery disease, and mortality, highlighting the NLRP3 inflammasome as a therapeutic target for cardiovascular diseases.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Peripheral Vascular Disease

Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years

Agostino Virdis et al.

HYPERTENSION (2020)

Add to Collection

Review Peripheral Vascular Disease

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project

Alessandro Maloberti et al.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2020)

Add to Collection

Article Cell Biology

Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4

Samantha Milanesi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Add to Collection

Article Urology & Nephrology

Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis

Qimei Luo et al.

BMC NEPHROLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care

Hirotake Okazaki et al.

ESC HEART FAILURE (2019)

Add to Collection

Article Peripheral Vascular Disease

Uric acid is linked to cardiometabolic risk factors in overweight and obese youths

Empar Lurbe et al.

JOURNAL OF HYPERTENSION (2018)

Add to Collection

Review Endocrinology & Metabolism

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Claudio Franceschi et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Add to Collection

Review Immunology

NLRP3 inflammasome activation in inflammaging

Eicke Latz et al.

SEMINARS IN IMMUNOLOGY (2018)

Add to Collection

Article Peripheral Vascular Disease

Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study

Giovambattista Desideri et al.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2018)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

HDL cholesterol concentration or HDL function: which matters?

Philip J. Barter et al.

EUROPEAN HEART JOURNAL (2017)

Add to Collection

Review Medicine, General & Internal

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies

Xue Li et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Review Medicine, General & Internal

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies

Xue Li et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Urology & Nephrology

Impact of Uric Acid Levels on Kidney Disease Progression

Hernan Rincon-Choles et al.

AMERICAN JOURNAL OF NEPHROLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications

Wolfram Doehner et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Add to Collection

Article Urology & Nephrology

Serum Uric Acid and Risk of CKD in Type 2 Diabetes

Salvatore De Cosmo et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Add to Collection

Article Endocrinology & Metabolism

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

Kunihiro Matsushita et al.

LANCET DIABETES & ENDOCRINOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Uric Acid Is Independently Associated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population

Dandan Yan et al.

PLOS ONE (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

Uric acid and risk of heart failure: a systematic review and meta-analysis

He Huang et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association between hyperuricemia and incident heart failure among older adults: A propensity-matched study

O. James Ekundayo et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.